Nuvo Pharmaceuticals Inc. (TSX:MRV) is looking for acquisitions. Jesse Ledger said, "Our second pathway to growth is through inorganic business development opportunities. We are actively seeking to in-license new and innovative products that leverage our existing infrastructure, looking to acquire complementary on-market brands that bolt on to this commercial infrastructure and to identify and acquire businesses that provide opportunities to realize synergies on integration into our infrastructure".
1st Jan change | Capi. | |
---|---|---|
+32.95% | 700B | |
+26.51% | 569B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B |